SCHEMBL21751683

SCHEMBL21751683

C[Si](C)(C)CCOC(Br)c1cc2cc[nH]c2nc1COCC(N)=O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.30
▸ HSP90AB1 P08238 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21751780 0.88 PDE3B (0.33) —
SCHEMBL21751713 0.82 CDK8 (0.33) —
SCHEMBL23908158 0.79 RIPK1 (0.30) —
SCHEMBL21751681 0.79 CDK8 (0.36) —
SCHEMBL21751742 0.74 — —
SCHEMBL21751629 0.74 — —
SCHEMBL21751559 0.73 MTNR1A (0.36) —
SCHEMBL23908110 0.70 CYP2C9 (0.33) —
SCHEMBL21751728 0.67 — —
SCHEMBL21751635 0.67 MAPT (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110298-A1 HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR Guangzhou Lupeng Pharmaceutical Company Ltd. (CN) 2023-01-04 — — EP disclosed
WO-2020041406-A1 BCL-2 INHIBITORS NEWAVE PHARMACEUTICAL INC. (US) 2020-02-27 — — WO disclosed
Send feedback